Literature DB >> 24726658

Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner.

Katarzyna Drela1, Anna Sarnowska1, Patrycja Siedlecka1, Ilona Szablowska-Gadomska1, Miroslaw Wielgos2, Marcin Jurga3, Barbara Lukomska1, Krystyna Domanska-Janik4.   

Abstract

BACKGROUND AIMS: As we approach the era of mesenchymal stem cell (MSC) application in the medical clinic, the standarization of their culture conditions are of the particular importance. We re-evaluated the influences of oxygens concentration on proliferation, stemness and differentiation of human umbilical cord Wharton Jelly-derived MSCs (WJ-MSCs).
METHODS: Primary cultures growing in 21% oxygen were either transferred into 5% O2 or continued to grow under standard 21% oxygen conditions. Cell expansion was estimated by WST1/enzyme-linked immunosorbent assay or cell counting. After 2 or 4 weeks of culture, cell phenotypes were evaluated using microscopic, immunocytochemical, fluorescence-activated cell-sorting and molecular methods. Genes and proteins typical of mesenchymal cells, committed neural cells or more primitive stem/progenitors (Oct4A, Nanog, Rex1, Sox2) and hypoxia inducible factor (HIF)-1α-3α were evaluated.
RESULTS: Lowering O2 concentration from 21% to the physiologically relevant 5% level substantially affected cell characteristics, with induction of stemness-related-transcription-factor and stimulation of cell proliferative capacity, with increased colony-forming unit fibroblasts (CFU-F) centers exerting OCT4A, NANOG and HIF-1α and HIF-2α immunoreactivity. Moreover, the spontaneous and time-dependent ability of WJ-MSCs to differentiate into neural lineage under 21% O2 culture was blocked in the reduced oxygen condition. Importantly, treatment with trichostatin A (TSA, a histone deacetylase inhibitor) suppressed HIF-1α and HIF-2α expression, in addition to blockading the cellular effects of reduced oxygen concentration.
CONCLUSIONS: A physiologically relevant microenvironment of 5% O2 rejuvenates WJ-MSC culture toward less-differentiated, more primitive and faster-growing phenotypes with involvement of HIF-1α and HIF-2α-mediated and TSA-sensitive chromatin modification mechanisms. These observations add to the understanding of MSC responses to defined culture conditions, which is the most critical issue for adult stem cells translational applications.
Copyright © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  SRTF/HIF gene profiles; TSA effect; WJ MSC culture; cell development; differentiation; influence of oxygen concentration; proliferation

Mesh:

Substances:

Year:  2014        PMID: 24726658     DOI: 10.1016/j.jcyt.2014.02.009

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  30 in total

Review 1.  In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.

Authors:  Fatemeh Amiri; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-12-20       Impact factor: 3.667

Review 2.  Molecular mechanism of extrinsic factors affecting anti-aging of stem cells.

Authors:  Tzyy Yue Wong; Mairim Alexandra Solis; Ying-Hui Chen; Lynn Ling-Huei Huang
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

3.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

4.  Hypoxic culture enhances the expansion of rat bone marrow-derived mesenchymal stem cells via the regulatory pathways of cell division and apoptosis.

Authors:  Jun Zhang; Lei Xiong; Wenxian Tang; Lin Tang; Baohe Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-22       Impact factor: 2.416

5.  Effect of MRI tags: SPIO nanoparticles and 19F nanoemulsion on various populations of mouse mesenchymal stem cells.

Authors:  Ghulam Muhammad; Anna Jablonska; Laura Rose; Piotr Walczak; Miroslaw Janowski
Journal:  Acta Neurobiol Exp (Wars)       Date:  2015       Impact factor: 1.579

6.  Tissue-Resident PDGFRα+ Progenitor Cells Contribute to Fibrosis versus Healing in a Context- and Spatiotemporally Dependent Manner.

Authors:  Maria Paola Santini; Daniela Malide; Gabriel Hoffman; Gaurav Pandey; Valentina D'Escamard; Aya Nomura-Kitabayashi; Ilsa Rovira; Hiroshi Kataoka; Jordi Ochando; Richard P Harvey; Toren Finkel; Jason C Kovacic
Journal:  Cell Rep       Date:  2020-01-14       Impact factor: 9.423

7.  Autoserum: An Optimal Supplement for Bone Marrow Mesenchymal Stem Cells of Liver-Injured Rats.

Authors:  Qinglin Zhang; Xun Sun; Jianxun Ding; Ping He; Yujia Liu; Hongjing Cheng; Changlin Zhou; Xiangwei Meng
Journal:  Stem Cells Int       Date:  2015-05-24       Impact factor: 5.443

8.  Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and neuroprotection.

Authors:  XiYou Wang; CuiLong Liu; ShaoDan Li; Yong Xu; Ping Chen; Yi Liu; Qiang Ding; Wasilijiang Wahafu; BaoFa Hong; MingHui Yang
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

9.  A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells.

Authors:  Anita Laitinen; Sofia Oja; Lotta Kilpinen; Tanja Kaartinen; Johanna Möller; Saara Laitinen; Matti Korhonen; Johanna Nystedt
Journal:  Cytotechnology       Date:  2015-03-17       Impact factor: 2.058

Review 10.  Strategies to improve the immunosuppressive properties of human mesenchymal stem cells.

Authors:  Myoung Woo Lee; Somi Ryu; Dae Seong Kim; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Stem Cell Res Ther       Date:  2015-10-07       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.